APGYX | VIGAX | APGYX / VIGAX | |
Total Expense Ratio | 0.57 | 0.05 | 1,140% |
Annual Report Gross Expense Ratio | 0.58 | 0.05 | 1,160% |
Fund Existence | 29 years | 25 years | - |
Gain YTD | 2.514 | 1.951 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 26.7B | 294B | 9% |
Annual Yield % from dividends | 0.05 | 0.46 | 12% |
Returns for 1 year | 1.04 | 12.60 | 8% |
Returns for 3 years | 62.84 | 91.62 | 69% |
Returns for 5 years | 65.31 | 115.23 | 57% |
Returns for 10 years | 161.91 | 286.61 | 56% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BTAL | 18.83 | 0.25 | +1.35% |
AGF U.S. Market Neutral Anti-Beta | |||
FMAR | 43.80 | -0.35 | -0.79% |
FT Vest US Equity Buffer ETF Mar | |||
PSL | 108.88 | -0.98 | -0.89% |
Invesco DW Consumer Staples Momt ETF | |||
BBP | 60.00 | -0.56 | -0.92% |
Virtus LifeSci Biotech Products ETF | |||
VIGI | 89.96 | -1.20 | -1.32% |
Vanguard Intl Div Apprec ETF |